Aarey Drugs & Pharmaceuticals Limited
NSE: AAREYDRUGS
NSE
89.50
1.50 (1.70%)
Prev Close
88
Open Price
88.5
Volume
8,204
Today Low / High
88.5 / 89.5
52 WK Low / High
32.85 / 90.4
Range
85 - 94
Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 89.5, with a change of 1.5 (1.70455%). The expected target range on the NSE is between 85 - 94. The stock is trending upwards on the NSE, which could present a good opportunity for potential investors.
27 Oct
88.50
1.13%
24 Oct
90.40
-2.65%
23 Oct
88.55
0.51%
21 Oct
89.00
0.00%
20 Oct
86.14
4.07%
17 Oct
88.02
-0.14%
16 Oct
88.58
0.00%
15 Oct
86.85
0.00%
14 Oct
83.50
1.98%
13 Oct
80.40
3.86%
10 Oct
79.71
2.87%
09 Oct
82.00
-0.80%
08 Oct
83.81
-0.97%
07 Oct
84.00
0.00%
06 Oct
80.57
4.07%
03 Oct
83.00
-0.94%
01 Oct
81.18
3.35%
30 Sep
82.39
0.55%
29 Sep
79.40
1.75%
Aarey Drugs & Pharmaceuticals Limited Graph
Aarey Drugs & Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Aarey Drugs & Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 89.50, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 89.50 | 90.40 | 81.36 - 99.43 |
| 91.29 | 73.03 - 109.55 | ||
| 92.19 | 64.53 - 119.84 | ||
| Bearish Scenario | 89.50 | 88.61 | 79.74 - 97.47 |
| 87.71 | 70.17 - 105.25 | ||
| 86.82 | 60.77 - 112.86 |
Overview of Aarey Drugs & Pharmaceuticals Limited
ISIN
INE198H01019
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
45,023
Market Cap
2,537,710,119
Last Dividend
0
Official Website
IPO Date
2021-08-06
DCF Diff
134.88
DCF
-46
Financial Ratios Every Investor Needs
Stock Dividend of AAREYDRUGS
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2018-12-13 | December 13, 18 | 0.1 | 0.1 | 2018-12-14 | 2018-12-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 473.94 Cr | 464.81 Cr | 9.13 Cr | 0.0193 | 0.00 Cr | 1.34 Cr | 0.31 Cr | 4.02 Cr | 1.43 | 12.06 Cr | 0.0085 |
| 2024-03-31 | 395.10 Cr | 381.90 Cr | 13.20 Cr | 0.0334 | 0.00 Cr | 0.42 Cr | 2.82 Cr | 4.68 Cr | 1.84 | 11.42 Cr | 0.0119 |
| 2023-03-31 | 418.96 Cr | 403.84 Cr | 11.51 Cr | 0.0275 | 0.00 Cr | 0.88 Cr | 13.53 Cr | 3.77 Cr | 1.49 | 10.45 Cr | 0.0090 |
| 2022-03-31 | 491.61 Cr | 472.06 Cr | 19.54 Cr | 0.0398 | 0.00 Cr | 0.61 Cr | 11.77 Cr | 6.55 Cr | 2.72 | 14.06 Cr | 0.0133 |
| 2021-03-31 | 347.89 Cr | 337.79 Cr | 10.10 Cr | 0.0290 | 0.00 Cr | 0.32 Cr | 3.87 Cr | 6.51 Cr | 2.79 | 11.67 Cr | 0.0187 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.47 Cr | 238.27 Cr | 99.79 Cr | 138.4805 Cr | 34.86 Cr | 33.38 Cr | 45.48 Cr | 16.22 Cr | 0.00 Cr | 0.00 Cr | 3.10 Cr | 96.8804 Cr |
| 2024-03-31 | 1.59 Cr | 303.29 Cr | 170.52 Cr | 132.7734 Cr | 31.35 Cr | 29.76 Cr | 71.99 Cr | 12.96 Cr | 0.00 Cr | 0.00 Cr | 2.09 Cr | 166.5469 Cr |
| 2023-03-31 | 0.71 Cr | 291.32 Cr | 173.91 Cr | 117.4138 Cr | 37.72 Cr | 37.01 Cr | 65.18 Cr | 13.94 Cr | 5.28 Cr | 0.00 Cr | 1.19 Cr | 168.1349 Cr |
| 2022-03-31 | 0.19 Cr | 245.17 Cr | 131.53 Cr | 113.6373 Cr | 14.16 Cr | 13.97 Cr | 56.12 Cr | 14.47 Cr | 0.89 Cr | 0.00 Cr | 2.80 Cr | 126.7362 Cr |
| 2021-03-31 | 0.64 Cr | 233.04 Cr | 134.18 Cr | 98.8605 Cr | 18.02 Cr | 17.38 Cr | 46.93 Cr | 14.26 Cr | 0.00 Cr | 0.00 Cr | 0.40 Cr | 130.8039 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.8948 Cr | -5.9394 Cr | 4.9237 Cr | -4.3096 Cr | -0.1211 Cr | 1.4733 Cr | -5.2044 Cr | 4.0239 Cr | 3.2337 Cr | 0.0000 Cr | -10.8045 Cr |
| 2024-03-31 | -2.9938 Cr | -1.7023 Cr | 5.5848 Cr | -3.7161 Cr | 0.8886 Cr | 1.5944 Cr | -0.7223 Cr | 4.6837 Cr | -1.1362 Cr | 0.0000 Cr | -5.8566 Cr |
| 2023-03-31 | -1.2811 Cr | 0.4410 Cr | 1.3540 Cr | -2.3251 Cr | 0.5139 Cr | 0.7058 Cr | -1.0440 Cr | 6.0151 Cr | 4.2211 Cr | 0.0000 Cr | -15.1352 Cr |
| 2022-03-31 | -4.4930 Cr | -2.1967 Cr | 2.2534 Cr | -6.6943 Cr | -0.4578 Cr | 0.1919 Cr | -2.2013 Cr | 10.0271 Cr | -3.9786 Cr | 0.0000 Cr | 4.7767 Cr |
| 2021-03-31 | 5.4770 Cr | -2.8793 Cr | -2.4507 Cr | 2.5977 Cr | 0.1470 Cr | 0.6497 Cr | -2.8793 Cr | 8.3014 Cr | -0.0191 Cr | 0.0000 Cr | -1.4646 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 102.21 Cr | 97.84 Cr | 4.37 Cr | 0.0428 | 1.22 Cr | 1.37 Cr | 0.48 | 3.25 Cr | 0.0134 |
| 2025-03-31 | 108.10 Cr | 108.02 Cr | 0.08 Cr | 0.0007 | -3.43 Cr | 0.47 Cr | 0.17 | 2.69 Cr | 0.0043 |
| 2024-12-31 | 133.79 Cr | 130.39 Cr | 3.40 Cr | 0.0254 | 1.62 Cr | 0.72 Cr | 0.26 | 2.88 Cr | 0.0054 |
| 2024-09-30 | 105.14 Cr | 98.90 Cr | 6.24 Cr | 0.0594 | 3.23 Cr | 1.60 Cr | 0.57 | 3.74 Cr | 0.0152 |
| 2024-06-30 | 126.91 Cr | 123.59 Cr | 3.32 Cr | 0.0261 | 2.58 Cr | 1.24 Cr | 0.44 | 2.75 Cr | 0.0098 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 3.23 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -138.48 Cr |
| 2025-03-31 | 1.47 Cr | 1.76 Cr | 1.47 Cr | 159.55 Cr | 45.48 Cr | 213.28 Cr | 16.22 Cr | 238.27 Cr | 99.79 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 1.49 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -135.59 Cr |
| 2024-09-30 | 1.49 Cr | 0.00 Cr | 1.49 Cr | 23.52 Cr | 29.84 Cr | 251.35 Cr | 12.99 Cr | 274.53 Cr | 138.94 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 2.89 Cr | 0.00 Cr | 0.00 Cr | 2.89 Cr | 0.00 Cr | 0.00 Cr | -132.77 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 1.37 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 0.47 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 0.72 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 1.60 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 1.24 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,694.90 | ₹4,066,626,700,030.00 | ₹2,067,838.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,490.00 | ₹1,722,896,483,880.00 | ₹342,162.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,587.70 | ₹1,214,239,126,500.00 | ₹118,062.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,285.00 | ₹1,069,587,836,375.00 | ₹1,927,981.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹1,012.25 | ₹1,018,555,873,122.00 | ₹506,429.00 |
| Mankind Pharma Limited | MANKIND | ₹2,412.70 | ₹995,862,408,823.00 | ₹242,917.00 |
| Lupin Limited | LUPIN | ₹1,920.00 | ₹876,975,106,560.00 | ₹242,714.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,449.00 | ₹651,509,685,000.00 | ₹71,440.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,093.00 | ₹634,816,173,939.00 | ₹1,422,794.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,815.60 | ₹512,363,788,820.00 | ₹1,249,674.00 |
| Laurus Labs Limited | LAURUSLABS | ₹940.00 | ₹507,435,405,060.00 | ₹4,885,410.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,296.00 | ₹328,800,666,528.00 | ₹84,835.00 |
| Cohance Lifesciences Limited | COHANCE | ₹851.00 | ₹325,564,636,140.00 | ₹321,672.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,392.80 | ₹298,945,961,107.00 | ₹72,314.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,701.40 | ₹266,432,841,035.00 | ₹65,655.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹9,319.00 | ₹232,975,000,000.00 | ₹11,086.00 |
| Eris Lifesciences Limited | ERIS | ₹1,625.00 | ₹221,347,025,250.00 | ₹73,181.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,291.50 | ₹209,849,120,492.00 | ₹582,354.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹15,722.00 | ₹201,711,514,858.00 | ₹17,643.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹915.00 | ₹179,855,258,460.00 | ₹97,186.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,124.00 | ₹178,211,081,216.00 | ₹180,809.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,011.40 | ₹152,889,925,334.00 | ₹34,364.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹825.00 | ₹147,765,642,750.00 | ₹437,125.00 |
| Granules India Limited | GRANULES | ₹565.00 | ₹137,107,824,540.00 | ₹622,818.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,148.00 | ₹102,053,000,536.00 | ₹6,238.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹830.00 | ₹75,225,364,270.00 | ₹73,863.00 |
| Strides Pharma Science Limited | STAR | ₹808.20 | ₹74,493,987,455.00 | ₹139,266.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹370.00 | ₹72,365,271,920.00 | ₹150,217.00 |
| FDC Limited | FDC | ₹432.00 | ₹70,333,956,288.00 | ₹74,529.00 |
| Sequent Scientific Limited | SEQUENT | ₹204.31 | ₹51,059,694,179.00 | ₹627,687.00 |
| Innova Captab Limited | INNOVACAP | ₹805.00 | ₹46,066,067,845.00 | ₹8,877.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹491.10 | ₹44,822,697,000.00 | ₹99,137.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹132.82 | ₹43,102,957,318.00 | ₹356,495.00 |
| Suven Life Sciences Limited | SUVEN | ₹196.50 | ₹42,844,996,961.00 | ₹236,733.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,366.10 | ₹39,132,963,392.00 | ₹5,733.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹713.55 | ₹36,190,617,373.00 | ₹35,281.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹335.00 | ₹33,594,639,510.00 | ₹34,318.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹470.00 | ₹33,090,702,500.00 | ₹5,635.00 |
| Hikal Limited | HIKAL | ₹241.50 | ₹29,777,131,125.00 | ₹117,277.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹93.00 | ₹27,298,058,430.00 | ₹1,022,274.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹48.50 | ₹26,575,754,402.00 | ₹878,042.00 |
Key Executives
Chief Accountant
Mr. A. S. Kathawala
Gender: male
Year Born: 1976
Company Secretary & Compliance Officer
Mr. Kailash Chand Jethlia
Gender: male
Year Born:
Chairman & MD
Mr. Mihir Rajesh Ghatalia B.E
Gender: male
Year Born: 1983
Chief Financial Officer
Ms. Mira Mihir Ghatalia
Gender: female
Year Born:
Executive Director
Mr. Nimit Rajesh Ghatalia
Gender: male
Year Born: 1996
FAQs about Aarey Drugs & Pharmaceuticals Limited
Who is the CEO of the company?
The CEO is Mihir Rajesh Ghatalia.
What is the current market price of the stock?
The current price is ₹89.50.
What is the 52-week price range?
The range is ₹32.85-90.4.
What is the market capitalization of the company?
The market capitalization is ₹253.77 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 61.28.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Aarey Drugs & Pharmaceuticals Limited (ISIN: INE198H01019) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹253.77 crores and an average daily volume of 45,023 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.